[Federal Register Volume 66, Number 215 (Tuesday, November 6, 2001)]
[Notices]
[Page 56087]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-27867]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Antileishmanial Composition for 
Topical Application

AGENCY: Army Medical Research and Materiel Command, DOD.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 6,284,739 entitled 
``Antileishmanial Composition for Topical Application'' issued Sept. 4, 
2001. Foreign rights are also available (PCT/US98/08979). The United 
States Government as represented by the Secretary of the Army has 
rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For issuing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The instant invention provides compositions 
containing as active agents paromomycin in combination with gentamicin. 
When given in combination, the compositions appear much more effective 
than when given alone. Furthermore, the compositions of the invention 
were found to be effective against several species of Leishmania that 
were not effectively inhibited by the prior art compositions.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-27867 Filed 11-5-01; 8:45 am]
BILLING CODE 3710-08-M